YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Thermo Fisher Scientific (NYSE:TMO) has helped launch the Digital CMC Consortium to advance digital Chemistry, Manufacturing, and Controls for biopharma. The initiative brings together biopharma companies, technology providers, and regulat…
Thermo Fisher Scientific (TMO) just appeared in the headlines after its clinical research business signed a Study Start-Up Agreement with Quantum BioPharma to run a Phase 2 multiple sclerosis trial for Lucid-MS. For context, Thermo Fisher…
Company Logo Five-year forecasts by application, technology, product and setting, from clinical labs to point of care, as syndromic multiplex panels reshape molecular diagnostics after the pandemic. Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -…
Company Logo 230-Page Report Shows How 569,000+ Registered Clinical Studies, CRO Consolidation and AI-Driven Trial Models Are Reshaping Outsourcing Strategy for Pharma and Biotech Leaders Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- "Pharmace…
New agreement moves innovative Lucid-MS treatment from planning into execution. Proprietary platform is designed around a novel neuroprotective approach that targets demyelination rather than solely modulating the immune system. Thermo Fis…
Thermo Fisher Scientific Inc. TMO is strengthening growth through innovation, artificial intelligence (AI) investments, customer partnerships and a broad commercial engine. Targeted acquisitions are further broadening its capabilities acro…
Company Logo 281-Page Report Tracks Post-Pandemic Research Growth Across Pharma, Research and Industry/Cosmetic Users as 3D Assays, Automation and Immuno-oncology Reshape Drug Discovery Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "Cell-Based…
ClearBridge Investments, a global equity manager, recently published third-quarter 2026 commentary for its "Large Cap Growth Strategy". The letter can be downloaded here. In the third quarter, leadership among large growth stocks shifted f…
Quantum BioPharma Strategic collaboration with leading global contract research organization to implement randomized, double-blind, placebo-controlled Phase 2 study of novel neuroprotective therapy TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -…
Uniting industry leaders to build the digital standards and infrastructure needed for the future of drug development DOVER, Del., Oct. 6, 2026 /PRNewswire/ -- The Digital CMC Consortium today launched as a new industry collaboration unitin…
Quantum BioPharma Ltd. (NASDAQ:QNTM) on Tuesday said it is partnering with the clinical research division of Thermo Fisher Scientific Inc.(NYSE:TMO) to launch a Phase 2 clinical trial for its multiple sclerosis treatment, Lucid-MS. The com…
New development solutions, expanded global capacity, and advanced digital technologies help pharma and biotech companies reduce complexity and scale toward commercialization Key facts New solutions for drug product development: New OSD Exp…
For Immediate Release Chicago, IL – October 6, 2026 – Today, Zacks Equity as Globus Medical GMED, Intuitive Surgical ISRG and Thermo Fisher Scientific TMO. Industry: Medical Instruments Link: https://www.zacks.com/ commentary/2999820/3-med…
Initial results presented at HUPO 2026 World Congress demonstrate how the company's complementary mass spectrometry and Olink biomarker panels can expand biological associations at population scale to advance disease and therapeutic develo…
Generative AI (GenAI) is gaining traction across the Medical Instruments industry as companies move from experimentation to practical applications. The technology is being used togenerate synthetic medical images, simulate disease progress…
The three benchmark Wall Street indexes delivered mixed performance for the week ended October 2, 2026. The Dow Jones Industrial Average fell 1.26%, while the S&P 500 declined 0.27%. The Nasdaq Composite, however, gained 0.45%. Stocks face…
Company Logo Dublin, Oct. 05, 2026 (GLOBE NEWSWIRE) -- "Custom Recombinant Proteins Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global custom recombinant proteins market was valued at…
[Close-Up Shot of Scientists Hands typing Data in Laptop in Laboratory] Tom Werner Healthcare stocks underperformed the broader market in September, with the Health Care Select Sector SPDR Fund (XLV [https://seekingalpha.com/symbol/XLV]) f…
QIAGEN N.V. QGEN announced that U.S. laboratories now have access to its complete QIAstat-Dx bloodstream infection portfolio following FDA clearance of a new panel. The new QIAstat-Dx BCID GN Plus AMR Panel identifies gram-negative bacteri…
Company Logo Boost ROI with scalable viral-vector platforms, automated single-use processing, digital quality control, and expanded CDMO capacity through partnerships and acquisitions. Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- "Cell and Ge…
Company Logo The global biomarkers market is projected to grow from USD 67.95 billion in 2026 to USD 112.10 billion by 2031, registering a 10.5% CAGR. Growth is driven by precision medicine, companion diagnostics, AI, bioinformatics, digit…
Company Logo The global radiation detection, monitoring & safety market is projected to grow from USD 3.80 billion in 2026 to USD 5.68 billion by 2031, at an 8.4% CAGR. Growth is driven by expanding medical imaging and radiotherapy, nuclea…
Company Logo Demand for biologics, targeted therapies and personalized medicine is rising, while AI-led protein design and scalable bioprocessing unlock new opportunities. Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Recombinant Proteins Ma…
Company Logo Fetal Bovine Serum Market Gains Momentum as Stem Cell Research, Vaccine Innovation and Advanced Therapies Drive Demand for High-Quality, Ethically Sourced Products Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Fetal Bovine Serum…
Thermo Fisher Scientific has been a strong performer over the past year, and that kind of run naturally raises a pointed question for anyone looking at the stock today. Is the current share price aligned with the cash flows the business is…
On September 23, Thermo Fisher Scientific Inc. (NYSE:TMO) announced the launch of the Gibco CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to accelerate cell growth and protein production for CHO-K1 host line…
Earlier this month, Thermo Fisher Scientific announced several product and collaboration updates, including the cGMP-ready Gibco CHO-K1 Catalog Panel for bioprocessing, a reseller agreement to distribute Evosep's Eno separation platform in…
Gilead Sciences, Inc. (NASDAQ:GILD) and Thermo Fisher Scientific Inc. (NYSE:TMO) are benefiting from two very different sources of growth. Gilead's momentum is being driven primarily by its HIV portfolio, where established medicines and ne…
Biodesix BDSX recently announced strategic progress in two molecular residual disease (MRD) programs to expand access to blood-based cancer monitoring. The company is developing tumor-informed and tumor-naive solutions that detect circulat…
WALTHAM, Mass., September 28, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2026 before the market opens on…
Company Logo Boost ROI through standardized QC, auditable automation, validated AI, diversified reagent sourcing, regional partnerships, and cross-skilled workforce training Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Cell Line Generation…
Company Logo Demand is rising in diagnostics, precision medicine and biopharma research, while nanotechnology, automation and AI unlock targeted therapies and high-throughput workflows. Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Magnetic…
Company Logo Boost ROI via automated closed handling, resilient sourcing, tailored portfolios, quality-by-design, validated AI, compliance mapping and lifecycle stewardship. Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Grignard Reagents Mar…
Evosep Thermo Fisher Scientific to offer the Evosep Eno separation platform to customers, expanding access to standardized, high-throughput proteomics workflows SINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Evosep™, a global leader in stan…
Pfizer Inc. (NYSE:PFE) and Thermo Fisher Scientific Inc. (NYSE:TMO) are both trying to put difficult post-pandemic periods behind them, but their recoveries look very different. Thermo Fisher is benefiting from improving activity across li…
Bio-Techne Corporation (NASDAQ:TECH) shareholders voted on September 23 to approve the company's acquisition by Merck KGaA of Darmstadt, Germany. The German group is paying $73 a share in cash, valuing the business at about $11.3 billion i…